13 December 2024
Medicina Webinar | Non-Motor Symptoms in Parkinsonian Syndromes, 23 December 2024

You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
Parkinson’s disease (PD) is the second most common multi-systemic neurodegenerative disorder that is characterized by a broad spectrum of motor and non-motor symptoms (NMSs). Atypical Parkinsonism is a less common group of sporadic, neurodegenerative diseases of the central nervous system but is more severe than PD. The most common forms are multiple system atrophy (MSA), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and dementia with Lewy bodies (DLB). Neuroanatomically, NMSs may be subdivided into cortical manifestations (psychosis and cognitive impairment), basal ganglia symptoms (impulse control disorders, apathy, and restlessness or akathisia), brainstem symptoms (depression, anxiety, and sleep disorders), peripheral nervous system disturbances (orthostatic hypotension (OH), constipation, and pain), and sensory disturbances. NMSs are often overlooked by physicians and dismissed by patients, thus making their management difficult and creating a major burden for patients and caregivers. Unfortunately, there are very little existing data about NMS, their neurobiology, their potential biomarkers, their monitoring, and their treatment. Moreover, there is growing evidence to support the accurate monitoring of NMSs using wearable sensors for PD. It is therefore essential that researchers and practitioners comprehensively address the factors related to NMS to improve the quality of life of PD patients.
Date: 23 December 2024 at 6:00 p.m. CET | 7:00 p.m. EET | 12:00 p.m. EST
Webinar ID: 816 1650 2976
Register now for free!
Program:
Speaker/Presentation |
Time in CEST |
Dr. Anastasia Bougea |
6:00–6:10 p.m. |
Prof. Yildiz Degirmenci |
6:10–6:30 p.m. |
Prof. Cristian Falup-Pecurariu |
6:30–6:50 p.m. |
Q&A Session |
7:10–7:25 p.m. |
Dr. Anastasia Bougea |
7:25–7:30 p.m. |
After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway, and we will inform you when the webinar recording is available for viewing.
Webinar Chair and Keynote Speakers:
Relevant Special Issue:
“Non-motor Disorders in Parkinson’s Disease and Other Parkinsonian Syndromes, 2nd Edition”
Guest Editor: Dr. Anastasia Bougea
Submission deadline: 30 June 2025